FIRM FIXED PRICENO SET ASIDE USED.

AMGEN USA INC - NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.

PIID: 36E79725D0053Solicitation ID: 36E79725R0038

Signed Date: Jan 20, 2026Effective Date: Nov 15, 2025

Vendor

AMGEN USA INC

NAICS

325412

Signed Date

Jan 20, 2026

Key Details

Dollars Obligated

Base & All Options

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Description

NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.

Context & Analysis

On Jan 20, 2026, Department of Veterans Affairs to AMGEN USA INC for new award for trastuzumab with amgen. ordering period is nov 15, 2025 through nov 14, 2026 with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.